Maggie Lu
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Nanoparticle-Based Drug Delivery 5
- Oncology 4
- Cancer Treatment and Pharmacology 2
- Co-authors
- Tai‐Tong Wong (2 shared papers)Hsiang‐Fa Liang (1 shared paper)Feng‐Yi Yang (1 shared paper)Chien Ho (2 shared papers)Li Liu (2 shared papers)Feng Yang (1 shared paper)Ming-Cheng Wei (2 shared papers)Yuan‐Hung Hsu (2 shared papers)
- Journals
- Supportive Care in Cancer (2 papers)Scientific Reports (2 papers)Journal of Controlled Release (2 papers)Cancer Biology & Therapy (1 paper)American Journal of Health-System Pharmacy (1 paper)
- Partner nations
- United StatesTaiwanVietnam
In The Last Decade
Maggie Lu
17 papers receiving 480 citations
Peers
Comparison fields: 5 of 90
- Biomaterials 193
- Molecular Medicine 29
- Biomedical Engineering 246
- Pharmaceutical Science 27
- Radiology, Nuclear Medicine and Imaging 79
Countries citing papers authored by Maggie Lu
This map shows the geographic impact of Maggie Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maggie Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maggie Lu more than expected).
Fields of papers citing papers by Maggie Lu
This network shows the impact of papers produced by Maggie Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maggie Lu. The network helps show where Maggie Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Maggie Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 160 | |
| 2 | 2015 | 65 | |
| 3 | 2012 | 63 | |
| 4 | 2019 | 48 | |
| 5 | 2015 | 47 | |
| 6 | 2017 | 30 | |
| 7 | 2015 | 20 | |
| 8 | 2015 | 14 | |
| 9 | 2013 | 14 | |
| 10 | 2018 | 10 | |
| 11 | 2007 | 9 | |
| 12 | The Harvard Business School guide to careers in management consulting | 2001 | 5 |
| 13 | 2016 | 3 | |
| 14 | 2023 | 2 | |
| 15 | 2024 | 1 | |
| 16 | 2024 | 1 | |
| 17 | 2013 | 1 | |
| 18 | 2024 | 0 |
About Maggie Lu
Maggie Lu is a scholar working on Biomaterials, Oncology, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Biomedical Engineering, having authored 18 papers that have together received 493 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (5 papers), Ultrasound Imaging and Elastography (2 papers), RNA Interference and Gene Delivery (2 papers), Cancer Treatment and Pharmacology (2 papers), Photoacoustic and Ultrasonic Imaging (2 papers), Ultrasound and Hyperthermia Applications (2 papers), Traumatic Brain Injury and Neurovascular Disturbances (1 paper) and Renal cell carcinoma treatment (1 paper). The work is most often cited by research in Biomaterials (193 citations), Molecular Medicine (29 citations), Biomedical Engineering (246 citations), Pharmaceutical Science (27 citations) and Radiology, Nuclear Medicine and Imaging (79 citations). Maggie Lu has collaborated with scholars based in United States, Taiwan and Vietnam. Frequent co-authors include Tai‐Tong Wong, Hsiang‐Fa Liang, Feng‐Yi Yang, Chien Ho, Li Liu, Feng Yang, Ming-Cheng Wei, Yuan‐Hung Hsu, Shen‐Chuan Lo and Daniel J. Bain. Their work appears in journals such as Supportive Care in Cancer, Scientific Reports, Journal of Controlled Release, Cancer Biology & Therapy and American Journal of Health-System Pharmacy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.